AIMT
Aimmune Therapeutics, Inc.
AIMT
AIMT
Delisted
AIMT was delisted on the 12th of October, 2020.
151 hedge funds and large institutions have $1.25B invested in Aimmune Therapeutics, Inc. in 2018 Q2 according to their latest regulatory filings, with 22 funds opening new positions, 69 increasing their positions, 35 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
151
Holders Change
-4
Holders Change %
-2.58%
% of All Funds
3.46%
Holding in Top 10
5
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-28.57%
% of All Funds
0.11%
New
22
Increased
69
Reduced
35
Closed
26
Calls
$7.2M
Puts
$4.19M
Net Calls
+$3.02M
Net Calls Change
+$7.5M
Top Buyers
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
$45.4M |
| 2 |
BlackRock
New York
|
$98M |
| 3 |
State Street
Boston,
Massachusetts
|
$63.7M |
| 4 |
SI
Sofinnova Investments
Menlo Park,
California
|
$10.1M |
| 5 |
Morgan Stanley
New York
|
$25.8M |
